Our recent study uncovered a mechanism by which loss of Aldob led to a novel mode of metabolic reprogramming through up-regulation of glycolysis, PPP, and TCA to promote HCC [18]. This evidence concerns the gene ALDOB and hepatocellular carcinoma.